Fluorescent separase activity sensor

US10174359B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10174359-B2
Application numberUS-201314413760-A
CountryUS
Kind codeB2
Filing dateJul 10, 2013
Priority dateJul 11, 2012
Publication dateJan 8, 2019
Grant dateJan 8, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Problem to be Solved An object of the present invention is to provide a separase sensor for visualizing separase activity in a living cell. Another object is to develop a function analysis system of cell division using the separase sensor and further obtain a simple screening method for an anticancer agent. Solution The separase sensor of the present invention has two types of fluorescent proteins different in fluorescence wavelength at both ends of an amino acid sequence containing a separase cleavage site and a localization-targeting sequence targeting to a specific site within a cell. Since timing of activating separase and location of separase in a cell can be specified by use of the sensor, cell division can be analyzed and an anticancer agent can be screened.

First claim

Opening claim text (preview).

The invention claimed is: 1. A biosensor for measuring and/or detecting separase activity in cultured cells, comprising: a first fluorescent substance at a first end of the fragment of human Scc1, said fragment consisting of the polypeptide of SEQ ID NO. 1; a second fluorescent substance at the second end of the fragment consisting of the polypeptide of SEQ ID NO. 1: and a localization-targeting sequence for localizing the biosensor at a localization site within the cultured cells, said localization-targeting sequence at the N- or C-terminus of the biosensor: wherein the localization-targeting sequence is not a sequence derived from Scc1; wherein the first fluorescent substance and the second fluorescent substance have non-overlapping emission wavelengths that do not cause excitation of each other; and wherein the biosensor is a separase sensor configured to detect and/or measure separase activity at the localization site within the cultured cells as a function of a change in emission fluorescence of the biosensor resulting from cleavage of the fragment consisting of the polypeptide of SEQ ID NO. 1 by separase. 2. The biosensor according to claim 1 , wherein the first and the second fluorescent substances are fluorescent proteins. 3. The biosensor according to claim 2 , wherein the localization-targeting sequence specifically localizes the biosensor at centromeres. 4. The biosensor according to claim 3 , wherein the localization-targeting sequence for centromeres is CENP-B. 5. A method to visualize and analyze proteolytic activity of separase in the context of chromosomal segregation in living cells, by transfected vector-derived separase sensor according to claim 4 . 6. A method for screening anticancer agents, comprising contacting test substances to the separase sensor according to claim 1 , visualizing the separase activity, and screening anticancer agents based on separase activity as an index. 7. The biosensor according to claim 2 , wherein the localization-targeting sequence specifically localizes the biosensor at chromosomes. 8. The biosensor according to claim 2 , wherein the localization-targeting sequence specifically localizes the biosensor at cytoplasmic membrane. 9. The biosensor according to claim 2 , wherein the localization-targeting sequence specifically localizes the biosensor at mitochondria. 10. The biosensor according to claim 7 , wherein the localization-targeting sequence for chromosomes is histone H2B.

Assignees

Inventors

Classifications

  • Separase (3.4.22.49) · CPC title

  • Cysteine endopeptidases (3.4.22) · CPC title

  • containing protease site · CPC title

  • containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title

  • Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10174359B2 cover?
Problem to be Solved An object of the present invention is to provide a separase sensor for visualizing separase activity in a living cell. Another object is to develop a function analysis system of cell division using the separase sensor and further obtain a simple screening method for an anticancer agent. Solution The separase sensor of the present invention has two types of…
Who is the assignee on this patent?
Japanese Found For Cancer Res
What technology area does this patent fall under?
Primary CPC classification C12Q1/37. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).